CXCR2 inhibition suppresses acute and chronic pancreatic inflammation von Steele, Colin W, Karim, Saadia A, Foth, Mona, Rishi, Loveena, Leach, Joshua DG, Porter, Ross J, Nixon, Colin, Jeffry Evans, TR, Carter, C Ross, Nibbs, Robert JB, Sansom, Owen J, Morton, Jennifer P

Volltext

Systemic therapy of hepatocellular carcinoma: Are we making progress? von Roxburgh, Patricia, Evans, T. R. Jeffry

Volltext

Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer von Morton, Jennifer P, Timpson, Paul, Karim, Saadia A, Ridgway, Rachel A, Athineos, Dimitris, Doyle, Brendan, Jamieson, Nigel B, Oien, Karin A, Lowy, Andrew M, Brunton, Valerie G, Frame, Margaret C, Evans, T.R. Jeffry, Sansom, Owen J

Volltext

Virotherapy: cancer gene therapy at last? [version 1; peer review: 2 approved] von Bilsland, Alan E, Spiliopoulou, Pavlina, Evans, T. R. Jeffry

Volltext

Antiproliferative effect of exemestane in lung cancer cells von Koutras, Angelos, Giannopoulou, Efstathia, Kritikou, Ismini, Antonacopoulou, Anna, Evans, T R Jeffry, Papavassiliou, Athanasios G, Kalofonos, Haralabos

Volltext

mTORC2 Signaling Drives the Development and Progression of Pancreatic Cancer von Driscoll, David R, Karim, Saadia A, Sano, Makoto, Gay, David M, Jacob, Wright, Yu, Jun, Mizukami, Yusuke, Gopinathan, Aarthi, Jodrell, Duncan I, Evans, T R Jeffry, Bardeesy, Nabeel, Hall, Michael N, Quattrochi, Brian J, Klimstra, David S, Barry, Simon T, Sansom, Owen J, Lewis, Brian C, Morton, Jennifer P

Volltext

Phase 1 dose-finding and pharmacokinetic study of eribulin-liposomal formulation in patients with solid tumours von Evans, T. R. Jeffry, Dean, Emma, Molife, L. Rhoda, Lopez, Juanita, Ranson, Malcolm, El-Khouly, Fatima, Zubairi, Ishtiaq, Savulsky, Claudio, Reyderman, Larisa, Jia, Yan, Sweeting, Lorna, Greystoke, Alastair, Barriuso, Jorge, Kristeleit, Rebecca

Volltext

A phase II open-label study of DHA-paclitaxel (Taxoprexin) by 2-h intravenous infusion in previously untreated patients with locally advanced or metastatic gastric or oesophageal a... von Jones, Robert J., Hawkins, Robert E., Eatock, Martin M., Ferry, David R., Eskens, Ferry A. L. M., Wilke, HansJochen, Evans, T. R. Jeffry

Volltext

Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours von Jones, Robin L., Ratain, Mark J., O'Dwyer, Peter J., Siu, Lillian L., Jassem, Jacek, Medioni, Jacques, DeJonge, Maja, Rudin, Charles, Sawyer, Michael, Khayat, David, Awada, Ahmad, de Vos-Geelen, Judith M.P.G.M., Evans, T.R. Jeffry, Obel, Jennifer, Brockstein, Bruce, DeGreve, Jacques, Baurain, Jean-Francois, Maki, Robert, D'Adamo, David, Dickson, Mark, Undevia, Samir, Geary, David, Janisch, Linda, Bedard, Philippe L., Abdul Razak, Albiruni R., Kristeleit, Rebecca, Vitfell-Rasmussen, Joanna, Walters, Ian, Kaye, Stan B., Schwartz, Gary

Volltext

A phase 1b/2, open-label, dose-escalation, and dose-confirmation study of eribulin mesilate in combination with capecitabine von Twelves, Chris, Anthoney, Alan, Savulsky, Claudio I., Guo, Matthew, Reyderman, Larisa, Cresti, Nicola, Semiglazov, Vladimir, Timcheva, Constanta, Zubairi, Ishtiaq, Morrison, Rosemary, Plummer, Ruth, Evans, T. R. Jeffry

Volltext

Five-year outcome for women randomised in a phase III trial comparing doxorubicin and cyclophosphamide with doxorubicin and docetaxel as primary medical therapy in early breast can... von Mansi, Janine L, Yellowlees, Ann, Lipscombe, Julian, Earl, Helena M, Cameron, David A, Coleman, Robert E, Perren, Timothy, Gallagher, Christopher J, Quigley, Mary, Crown, John, Jones, Alison L, Highley, Martin, Leonard, Robert C. F, Jeffry Evans, T. R

Volltext

Patient Selection for Oncology Phase I Trials: A Multi-Institutional Study of Prognostic Factors von OLMOS, David, A'HERN, Roger P, SCHELLENS, Jan H, DEL CONTE, Gianluca, BRUNETTO, Andre T, JEFFRY EVANS, T. R, WILSON, Richard, GALLERANI, Elisa, PLUMMER, Ruth, TABERNERO, Josep, SORIA, Jean-Charles, KAYE, Stan B, MARSONI, Silvia, MORALES, Rafael, GOMEZ-ROCA, Carlos, VERWEIJ, Jaap, VOEST, Emile E, SCHÖFFSKI, Patrick, JOO ERN ANG, PENEL, Nicolas

Volltext

Cancer cell senescence: a new frontier in drug development von Cairney, Claire J., Bilsland, Alan E., Evans, T.R. Jeffry, Roffey, Jon, Bennett, Dorothy C., Narita, Masashi, Torrance, Christopher J., Keith, W. Nicol

Volltext

Intravital FRAP Imaging using an E-cadherin-GFP Mouse Reveals Disease- and Drug-Dependent Dynamic Regulation of Cell-Cell Junctions in Live Tissue von Erami, Zahra, Herrmann, David, Warren, Sean C., Nobis, Max, McGhee, Ewan J., Lucas, Morghan C., Leung, Wilfred, Reischmann, Nadine, Mrowinska, Agata, Schwarz, Juliane P., Kadir, Shereen, Conway, James R.W., Vennin, Claire, Karim, Saadia A., Campbell, Andrew D., Gallego-Ortega, David, Magenau, Astrid, Murphy, Kendelle J., Ridgway, Rachel A., Law, Andrew M., Walters, Stacey N., Grey, Shane T., Croucher, David R., Zhang, Lei, Herzog, Herbert, Hardeman, Edna C., Gunning, Peter W., Ormandy, Christopher J., Evans, T.R. Jeffry, Strathdee, Douglas, Sansom, Owen J., Morton, Jennifer P., Anderson, Kurt I., Timpson, Paul

Volltext

Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial von Kudo, Masatoshi, Finn, Richard S, Qin, Shukui, Han, Kwang-Hyub, Ikeda, Kenji, Piscaglia, Fabio, Baron, Ari, Park, Joong-Won, Han, Guohong, Jassem, Jacek, Blanc, Jean Frederic, Vogel, Arndt, Komov, Dmitry, Evans, T R Jeffry, Lopez, Carlos, Dutcus, Corina, Guo, Matthew, Saito, Kenichi, Kraljevic, Silvija, Tamai, Toshiyuki, Ren, Min, Cheng, Ann-Lii

Volltext

SEARCH: a phase III, randomized, double-blind, placebo-controlled trial of sorafenib plus erlotinib in patients with advanced hepatocellular carcinoma von Zhu, Andrew X, Rosmorduc, Olivier, Evans, T R Jeffry, Ross, Paul J, Santoro, Armando, Carrilho, Flair Jose, Bruix, Jordi, Qin, Shukui, Thuluvath, Paul J, Llovet, Josep M, Leberre, Marie-Aude, Jensen, Markus, Meinhardt, Gerold, Kang, Yoon-Koo

Volltext

A multi-centre dose-escalation and pharmacokinetic study of diflomotecan in patients with advanced malignancy von Graham, Janet S., Falk, Stephen, Samuel, Leslie M., Cendros, Josep M., Evans, T. R. Jeffry

Volltext

CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma von Steele, Colin W., Karim, Saadia A., Leach, Joshua D.G., Bailey, Peter, Upstill-Goddard, Rosanna, Rishi, Loveena, Foth, Mona, Bryson, Sheila, McDaid, Karen, Wilson, Zena, Eberlein, Catherine, Candido, Juliana B., Clarke, Mairi, Nixon, Colin, Connelly, John, Jamieson, Nigel, Carter, C. Ross, Balkwill, Frances, Chang, David K., Evans, T.R. Jeffry, Strathdee, Douglas, Biankin, Andrew V., Nibbs, Robert J.B., Barry, Simon T., Sansom, Owen J., Morton, Jennifer P.

Volltext

Selumetinib in Combination With Dacarbazine in Patients With Metastatic Uveal Melanoma: A Phase III, Multicenter, Randomized Trial (SUMIT) von Carvajal, Richard D, Piperno-Neumann, Sophie, Kapiteijn, Ellen, Chapman, Paul B, Frank, Stephen, Joshua, Anthony M, Piulats, Josep M, Wolter, Pascal, Cocquyt, Veronique, Chmielowski, Bartosz, Evans, T R Jeffry, Gastaud, Lauris, Linette, Gerald, Berking, Carola, Schachter, Jacob, Rodrigues, Manuel J, Shoushtari, Alexander N, Clemett, Delyth, Ghiorghiu, Dana, Mariani, Gabriella, Spratt, Shirley, Lovick, Susan, Barker, Peter, Kilgour, Elaine, Lai, Zhongwu, Schwartz, Gary K, Nathan, Paul

Volltext

Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanoma von Cebon, Jonathan S, Gore, Martin, Thompson, John F, Davis, Ian D, McArthur, Grant A, Walpole, Euan, Smithers, Mark, Cerundolo, Vincenzo, Dunbar, P Rod, MacGregor, Duncan, Fisher, Cyril, Millward, Michael, Nathan, Paul, Findlay, Michael P N, Hersey, Peter, Evans, T R Jeffry, Ottensmeier, Christian Hermann, Marsden, Jeremy, Dalgleish, Angus G, Corrie, Pippa G, Maria, Marples, Brimble, Margaret, Williams, Geoff, Winkler, Sintia, Jackson, Heather M, Endo-Munoz, Liliana, Tutuka, Candani S A, Venhaus, Ralph, Old, Lloyd J, Haack, Dennis, Maraskovsky, Eugene, Behren, Andreas, Chen, Weisan

Volltext